What investors now expect from AI biotech companies

Israel pushes bioconvergence as next economic frontier

No Matter What: How Israel Is Positioning Itself as a Global Pharma Innovation Hub

Creating what nature has not from AI and computational molecular biophysics, with Kashif Sadiq

BIO-Europe Spring 2026: partnership event brings funding hope to biotechs

A complex biological landscape of protein function unlocked in Israel

Using AI to crack undruggable drug targets

Quantum technology gets a closer look at AION Labs

Insitro acquires CombinAble.AI, marking first Israeli exit for AI pharma startup

DenovAI’s physics-based bet on one-shot drug design